(Q27853123)
Statements
1 reference
Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer (English)
1 reference
March 2015
0 references
87
0 references
3
0 references
321-5
0 references